Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: A 40-Year-Old Man with Vasculitic Neuropathy

Martin Garber, DO, & David Fivenson, MD  |  Issue: October 2020  |  October 19, 2020

Figure 1: Nerve Biopsy

Figure 1: Nerve Biopsy
This image depicts the sural nerve biopsy with hematoxylin and eosin staining at 100x magnification. The black arrow indicates necrotizing vasculitis of epineural arterioles and muscular arteries with fibrinoid necrosis. The infiltrate is a mixture of neutrophils and mononuclear cells. There is luminal thrombosis with recannulation. Nerves (white arrow) show mildly thickened perineurium, but are relatively unaffected by inflammation.

Sural nerve and gastrocnemius biopsies were performed. Microscopic pathology showed a perineural, large arteriolar, necrotizing vasculitis consistent with PAN (see Figure 1).

We diagnosed vasculitic neuropathy and started our patient on monthly intravenous cyclophosphamide (500 mg/m2). After three months of treatment, he was not able to reduce his prednisone dose below 30 mg/day without worsening, painful dysesthesias in his feet and lower legs; additionally, his C-reactive protein remained elevated (5.8–8.9 mg/dL).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Another three months of intravenous cyclophosphamide at 750 mg/m2 was administered without improvement in his symptoms, C-reactive protein levels or prednisone requirement. Azathioprine was then tried, without any clinical benefit.

The previously fleeting leg rash became more persistent, and was joined by erythematous, reticulated macules on his arms and legs, and scattered purpuric papules. He also developed livedo racemosa, as well as slate-gray discoloration of the anterior lower legs, likely due to minocycline hyperpigmentation. A skin biopsy of an erythematous papule on his posterior left thigh demonstrated normal epidermis and superficial dermis with deep dermis and panniculus featuring intramural mixed inflammatory infiltrates of lymphocytes, histiocytes and neutrophils in medium and large vessels (see Figure 2). Direct immunofluorescence was negative for IgG, IgA, IgM and C3. The pathologic description was read as consistent with polyarteritis nodosa (PAN).

Figure 2: Skin Biopsy

Figure 2: Skin Biopsy
This image depicts the left posterior thigh biopsy of the soft tissue with hematoxylin and eosin staining at 100x magnification and shows necrotizing vasculitis of a deep dermal muscular artery with fibrinoid necrosis. The infiltrate is predominantly neutrophilic, and there is marked thrombosis of the arterial lumen. Concurrent direct immunofluorescence studies were negative.

Minocycline was identified as a potential trigger for the patient’s vasculitis and was discontinued. Within 30 days after stopping the minocycline, his rash resolved, his pain significantly improved and his C-reactive protein normalized (0.3 mg/dL). He received no more cyclophosphamide. Azathioprine was stopped, and prednisone was successfully weaned to 5 mg/day within one month and was stopped entirely by six months. Although he experienced persistent dysesthesias in his feet, presumed to be from permanent nerve damage, all of his other symptoms stabilized. At his three-year follow-up, he had experienced no further rashes or arthralgias, and his C-reactive protein remained normal.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:minocyclinepolyarteritis nodosavasculitic neuropathy

Related Articles
    A transverse view of the ulnar groove in full elbow extension. The red arrow indicates the advancing edge of the MHTr.

    Recurrent Medial Elbow Pain Following Successful Tommy John Surgery

    August 12, 2020

    A 27-year-old, left-handed man was referred to our ultrasound clinic for left elbow pain. History The patient had been a pitcher on a Minor League Baseball team. Two years before, he developed sudden, severe medial elbow pain while pitching in a game. The pain was associated with some tingling down the left medial forearm. The…

    Case Report: Hydralazine-Induced ANCA-Associated Vasculitis

    February 16, 2021

    Hydralazine has been in use as a treatment for hypertension, most notably in heart failure patients, since 1951.1 The drug is a known cause of autoimmune disease, most specifically hydralazine-induced lupus.  Hydralazine-induced lupus occurs in 7–13% of those taking the medication.2-4 It often presents with constitutional symptoms, arthritis/arthralgias, cutaneous lesions, sero­sitis, myalgias and/or hepatomegaly. Features…

    Ortho Angle

    August 1, 2009

    Where rheumatology and orthopedics meet

    Antiphospholipid Antibody Testing Update

    January 13, 2012

    Successes, challenges, and controversies of diagnostic methods for APS

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences